相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy
Nils Wellhausen et al.
CURRENT OPINION IN IMMUNOLOGY (2022)
CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma
Yelei Guo et al.
BLOOD ADVANCES (2022)
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Diana Gumber et al.
EBIOMEDICINE (2022)
Nanobody-based CAR-T cells for cancer immunotherapy
Pouya Safarzadeh Kozani et al.
BIOMARKER RESEARCH (2022)
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
Jaitip Tipanee et al.
MOLECULAR THERAPY (2022)
Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a
Xinyu Ling et al.
STAR PROTOCOLS (2022)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells
Khaled Sanber et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma
Kyung-Eun Noh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Base-edited CAR T cells for combinational therapy against T cell malignancies
Christos Georgiadis et al.
LEUKEMIA (2021)
'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Recent Advances in Allogeneic CAR-T Cells
Dong Wook Kim et al.
BIOMOLECULES (2020)
Gene editing and CRISPR in the clinic: current and future perspectives
Matthew P. Hirakawa et al.
BIOSCIENCE REPORTS (2020)
Gene modification strategies for next-generation CAR T cells against solid cancers
Yonggui Tian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery
Yulia Eygeris et al.
NANO LETTERS (2020)
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR
Dana Stenger et al.
BLOOD (2020)
Polyplexes for gene and nucleic acid delivery: Progress and bottlenecks
Kevin Ita
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei et al.
NATURE COMMUNICATIONS (2020)
Synthetic Notch-Receptor-Mediated Transmission of a Transient Signal into Permanent Information via CRISPR/Cas9-Based Genome Editing
Malte Sgodda et al.
CELLS (2020)
Efficient viral delivery of Cas9 into human safe harbor
Hideki Hayashi et al.
SCIENTIFIC REPORTS (2020)
Efficient Gene Editing of CART Cells with CRISPR-Cas12a for Enhanced Antitumor Efficacy
Elizabeth L. Siegler et al.
BLOOD (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells
Bian Hu et al.
HUMAN GENE THERAPY (2019)
Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies
Matthew R. Collinson-Pautz et al.
LEUKEMIA (2019)
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
Sareetha Kailayangiri et al.
MOLECULAR THERAPY (2019)
NR4A transcription factors limit CAR T cell function in solid tumours
Joyce Chen et al.
NATURE (2019)
CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
January Salas-Mckee et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma
Cesar Sommer et al.
MOLECULAR THERAPY (2019)
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
Shayesteh R. Ferdosi et al.
NATURE COMMUNICATIONS (2019)
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Stefan Stoiber et al.
CELLS (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion
Hyungseok Seo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T-cell therapy
Qianqian Gao et al.
CANCER MEDICINE (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Guangchuan Wang et al.
NATURE IMMUNOLOGY (2019)
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Rosalie M. Sterner et al.
BLOOD (2019)
Teaching an old dog new tricks: next-generation CAR T cells
Nicholas Tokarew et al.
BRITISH JOURNAL OF CANCER (2019)
Use of a Single CAR T Cell and Several Bispecific Adapters Facilitates Eradication of Multiple Antigenically Different Solid Tumors
Yong Gu Lee et al.
CANCER RESEARCH (2019)
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
Steven Feins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Quantifying CRISPR off-target effects
Soragia Athina Gkazi
EMERGING TOPICS IN LIFE SCIENCES (2019)
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz et al.
NEURO-ONCOLOGY (2018)
UDiTaS™, a genome editing detection method for indels and genome rearrangements
Georgia Giannoukos et al.
BMC GENOMICS (2018)
CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
In-Young Jung et al.
CANCER RESEARCH (2018)
CRISPR RNAs trigger innate immune responses in human cells
Sojung Kim et al.
GENOME RESEARCH (2018)
An off-the-shelf fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
Matthew L. Cooper et al.
LEUKEMIA (2018)
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
Christopher C. Kloss et al.
MOLECULAR THERAPY (2018)
Rewiring T-cell responses to soluble factors with chimeric antigen receptors
Zenan L. Chang et al.
NATURE CHEMICAL BIOLOGY (2018)
Thymic tolerance as a key brake on autoimmunity
Mickie Cheng et al.
NATURE IMMUNOLOGY (2018)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Jonathan D. Finn et al.
CELL REPORTS (2018)
Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager
Anna Wing et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi et al.
CANCER IMMUNOLOGY RESEARCH (2018)
CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
Hasan Mollanoori et al.
HUMAN IMMUNOLOGY (2018)
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Marco Ruella et al.
NATURE MEDICINE (2018)
Emerging Cellular Therapies for Cancer
Sonia Guedan et al.
Annual Review of Immunology (2018)
An Artificial Molecular Shuttle Operates in Lipid Bilayers for Ion Transport
Sujun Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo
Tia DiTommaso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TGF-β-responsive CAR-T cells promote anti-tumor immune function
Andrew J. Hou et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2018)
CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
Xiaojuan Liu et al.
CELL RESEARCH (2017)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
Shu Su et al.
ONCOIMMUNOLOGY (2017)
CRISPR knock out CTLA-4 enhances the anti-tumor activity of cytotoxic T lymphocytes
Long Shi et al.
GENE (2017)
Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
Daniel T. MacLeod et al.
MOLECULAR THERAPY (2017)
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
Iulia Diaconu et al.
MOLECULAR THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A versatile system for rapid multiplex genome-edited CAR T cell generation
Jiangtao Ren et al.
ONCOTARGET (2017)
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp et al.
SCIENTIFIC REPORTS (2017)
CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
Rasmus O. Bak et al.
CELL REPORTS (2017)
FCγ Chimeric Receptor-engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
Sara Caratelli et al.
FRONTIERS IN IMMUNOLOGY (2017)
CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells
Yongping Zhang et al.
FRONTIERS OF MEDICINE (2017)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Leonardo Morsut et al.
CELL (2016)
TGF-β Signaling in Cancer
Viqar Syed
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019)
Meenakshi Hegde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Lenka V. Hurton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation
Christian J. Braun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies
Nathan Singh et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Probing the Effect of miRNA on siRNA-PEI Polyplexes
Deniz Meneksedag-Erol et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel et al.
NATURE BIOTECHNOLOGY (2015)
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
Kathrin Schumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas-FasL-Dependent AICD
Annette Kuenkele et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Engineered T cells for cancer therapy
Carl H. June et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Plasma membrane recovery kinetics of a microfluidic intracellular delivery platform
Armon Sharei et al.
INTEGRATIVE BIOLOGY (2014)
Outcomes of patients with POEMS syndrome treated initially with radiation
Michael S. Humeniuk et al.
BLOOD (2013)
Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia
David S. Ritchie et al.
MOLECULAR THERAPY (2013)
Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis
Takashi Sekiya et al.
NATURE IMMUNOLOGY (2013)
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma
Bryan D. Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A vector-free microfluidic platform for intracellular delivery
Armon Sharei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Microfluidics-Based Assessment of Cell Deformability
Andrea Adamo et al.
ANALYTICAL CHEMISTRY (2012)
The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells
Alexander Shimabukuro-Vornhagen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
DNA Transposons: Nature and Applications in Genomics
Martin Munoz-Lopez et al.
CURRENT GENOMICS (2010)
piggyBac Transposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies
Pallavi V. Raja Manuri et al.
HUMAN GENE THERAPY (2010)
Polymers for gene delivery across length scales
David Putnam
NATURE MATERIALS (2006)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
